Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,689,446
+$887,827 QoQ
Shares Held
3,076
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#1,958
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $13,101,368 across 15 Drug Manufacturers - General names. LLY ranks #1 (28.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
3,076 | $3,689,446 | |
| 2 | JNJ |
Johnson & Johnson
|
9,737 | $2,472,905 | |
| 3 | AMGN |
Amgen Inc
|
4,049 | $1,466,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,140 | $1,431,490 | |
| 5 | ABBV |
AbbVie Inc.
|
4,882 | $1,228,506 | |
| 6 | NVS |
Novartis AG
|
5,542 | $868,542 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,306 | $536,211 | |
| 8 | GSK |
GSK plc
|
8,000 | $419,360 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,689,446 | 3,076 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,801,619 | 3,046 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,979,013 | 2,772 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,100,539 | 2,753 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $2,168,652 | 2,782 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $2,399,268 | 2,905 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,094,436 | 2,713 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $2,311,417 | 2,609 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $2,307,813 | 2,549 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,957,347 | 2,516 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,463,129 | 2,510 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,348,196 | 2,510 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,133,993 | 2,418 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $800,168 | 2,330 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $940,574 | 2,571 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $777,656 | 2,405 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $761,940 | 2,350 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $653,209 | 2,281 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $605,198 | 2,191 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $250,920 | 1,086 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $491,402 | 2,141 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $354,210 | 1,896 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $234,012 | 1,386 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $160,749 | 1,086 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $181,418 | 1,105 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $153,285 | 1,105 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||